NCT04810559View on ClinicalTrials.gov

Near Patient Study of the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test in Oral Fluid and Fingerstick Whole Blood

NACompletedINTERVENTIONAL

Enrollment

600

Participants

Timeline

Start Date

July 29, 2021

Primary Completion Date

February 28, 2023

Study Completion Date

June 30, 2024

Conditions

HIV TestingHIV Infections

Interventions

DEVICE

OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test

OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test in oral fluid and fingerstick blood conducted by untrained healthcare providers compared to laboratory 4th generation Ag/Ab EIA results performed on venous blood.

Trial Locations (4)

M5G 1K2

Maple Leaf Research, Toronto

Unknown

St. Michael's Hospital, Toronto

Women's Health in Women's Hands Community Health Centre, Toronto

Clinique médicale l'Actuel, Montreal

All Listed Sponsors

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Unity Health Toronto

OTHER

NCT04810559 - Near Patient Study of the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test in Oral Fluid and Fingerstick Whole Blood | Biotech Hunter | Biotech Hunter